Oral films as breakthrough tools for oral delivery of proteins/peptides

被引:38
作者
Castro, Pedro M. [1 ,2 ]
Fonte, Pedro [2 ,3 ]
Sousa, Flavia [2 ]
Madureira, Ana Raquel [1 ]
Sarmento, Bruno [2 ,4 ,5 ]
Pintado, Manuela E. [1 ]
机构
[1] Univ Catolica Portuguesa, Escola Super Biotecnol, Lab Assoc, CBQF, P-4202401 Porto, Portugal
[2] CESPU, Inst Invest & Formacao Avancada Ciencias & Tecnol, P-4585116 Gandra Prd, Portugal
[3] Univ Porto, Fac Pharm, Appl Chem Lab, REQUIMTE,Dept Chem Sci, P-4050313 Porto, Portugal
[4] Univ Porto, Inst Invest & Inovacao Saude, P-4050313 Porto, Portugal
[5] Univ Porto, Inst Biomed Engn, INEB, P-4150180 Porto, Portugal
关键词
Bioactive peptides; Bioactive proteins; Bioavailability enhancement; Oral delivery; Oral films; Stability; PEPTIDE DRUG-DELIVERY; BOVINE SERUM-ALBUMIN; GUANYLATE-CYCLASE C; BUCCAL DELIVERY; GASTROINTESTINAL-TRACT; BIOACTIVE PEPTIDES; ALPHA-LACTALBUMIN; PROTEIN; STABILIZATION; CHITOSAN;
D O I
10.1016/j.jconrel.2015.05.258
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Therapeutic proteins and peptides demonstrate unique, peerless, pharmacological characteristics such as high specificity to receptors and superior biological mimicking of physiological mechanisms, resulting in a better therapeutic index compared to conventional chemical-derived drugs. However, proteins also present inherent bioavailability limitations. Thus, this paper proposes several effective tools to improve protein/peptide drugs stability, permeability and pharmacokinetics with special emphasis on oral polymeric films as oral delivery platforms. Indeed, oral films present inherent characteristics that can greatly enhance biological performance of proteins and peptides and patient compliance along with other advantages that are critically discussed in this review. A rational choice of excipients addressed in and manufacture processes are also focused. In addition, possible toxicity issues to be overtaken and critical analysis regarding current market tendencies respecting oral films and protein/peptides along with future prospects are disclosed. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 110 条
[1]
Effect of protein thermo aggregation on the binding of BSA to gelatin type A [J].
Antonov, Y. A. ;
Zhuravleva, I. L. .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2013, 53 :160-167
[2]
Suppression of protein interactions by arginine: A proposed mechanism of the arginine effects [J].
Arakawa, Tsutomu ;
Ejima, Daisuke ;
Tsumoto, Kouhei ;
Obeyama, Noriyuki ;
Tanaka, Yoshikazu ;
Kita, Yoshiko ;
Timasheff, Serge N. .
BIOPHYSICAL CHEMISTRY, 2007, 127 (1-2) :1-8
[3]
Permeation enhancing polymers in oral delivery of hydrophilic macromolecules:: thiomer/GSH systems [J].
Bernkop-Schnürch, A ;
Kast, CE ;
Guggi, D .
JOURNAL OF CONTROLLED RELEASE, 2003, 93 (02) :95-103
[4]
Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants [J].
Blanco, D ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :285-294
[5]
Boateng JS, 2014, THER DELIV, V5, P497, DOI [10.4155/tde.14.21, 10.4155/TDE.14.21]
[6]
ENHANCEMENT OF THE STABILITY OF THROMBIN BY POLYOLS - MICROCALORIMETRIC STUDIES [J].
BOCTOR, AM ;
MEHTA, SC .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (07) :600-603
[7]
The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro [J].
Borchard, G ;
Luessen, HL ;
deBoer, AG ;
Verhoef, JC ;
Lehr, CM ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :131-138
[9]
Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines [J].
Brayden, DJ ;
O'Mahony, DJ .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (07) :291-299
[10]
Buanz A.B., 2014, INT J PHARM